IFNL3 and Hepatic fibrosis: The PPV for SVR of an HCV RNA viral decline of ≥1.5 log IU/mL at week 2 was analyzed relative to IL28B genotype (Figure 1A), liver fibrosis stage (Figure 1B), HCV genotype (Figure 1C), and baseline HCV RNA viral load (Figure 1D).